Fairhaven Health has launched two new products formulated to provide nutritional support for women affected by polycystic ovary syndrome (PCOS) and premenstrual syndrome (PMS).

PCOS affects an estimated 4-20% of reproductive-aged women, making it one of the most prevalent endocrine disorders. The condition is widely misunderstood, with symptoms that extend well beyond fertility challenges to include insulin resistance, type 2 diabetes risk, cardiovascular complications, and mental health concerns, such as anxiousness.

“PCOS is far more than a fertility concern. It’s a complex metabolic and cellular condition that impacts women’s health on many levels,” said Meagan Purdy, naturopathic doctor, brand manager and educator at Blueroot Health, the parent company of Fairhaven Health. “To truly support women, we must expand our focus beyond reproduction and provide options that address the wide range of symptoms they experience every day.”

The new supplement, PQQ+ Myo + D-Chiro Inositol, is designed to address common drivers of PCOS such as insulin resistance, oxidative stress, and mitochondrial dysfunction, which each play a role in cycle regularity, ovulation, and hormone balance. Inositol, specifically myo- and D-chiro inositol in a 40:1 ratio, have been studied for their roles in promoting ovulation and restoring menstrual regularity in women with PCOS within two cycles. This formula also features antioxidants such as PQQ, CoQ10, and alpha lipoic acid. Together, these ingredients support fertility and broader challenges women with PCOS face, the company reported.

The second formula, Multi-Symptom PMS Relief, is designed to provide nutritional support to women with PMS, the company reported, for cramps, bloating, mood swings, and more.

“Many women don’t realize that PMS and PCOS interact in ways that change the symptom picture,” said Purdy. “We’re committed to helping women and their providers distinguish between the two health concerns and providing more effective support strategies.”